PDL BIOPHARMA, INC. Note Agreements
3 Contracts & Agreements
- PDL BIOPHARMA, INC. 2.75% Convertible Senior Note due 2021 (Filed With SEC on November 28, 2016)
- NOTE PURCHASE AGREEMENT dated April 1, 2014 between ACCEL 300, LLC and THE PURCHASER NAMED HEREIN NOTES DUE JUNE 1, 2029 (Filed With SEC on August 18, 2014)
- PDL BIOPHARMA, INC. 2.875% SERIES 2012 CONVERTIBLE SENIOR NOTES DUE FEBRUARY 15,2015 INDENTURE DATEDAS OF JANUARY 5, 2012 THE BANK OF NEW YORK MELLON TRUST COMPANY, N. A. AS... (Filed With SEC on January 6, 2012)
